Novalis LifeSciences — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Telesis Biotelesisbio.comin𝕏Jun 2023 · $21M
Telesis Bio, Inc. is a company whose corporate governance page describes its Board of Directors and governance practices.
AI & Machine LearningBiotechDeep TechHardwareHealthtechSan Diego, US
Daniel G. Gibson(Executive Officer)inTodd R. Nelson(Executive Officer, Director)Eric Esser(Executive Officer)inWilliam F. Snider(Director)Andrea L. Jackson(Director)inChristine A. Tsingos(Director)
Co-investorsNorthpond Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.





